FDA Advisory Committee Unanimously Recommends Approval Of Novartis Investigational Treatment FTY720 To Treat Relapsing Remitting MS
Links shared publicly online about this topic.
- 965total visits
FDA Advisory Committee Unanimously Recommends Approval Of Novartis Investigational Treatment FTY720 To Treat Relapsing Remitting MS
An advisory committee of the US Food and Drug Administration (FDA) recommended approval of FTY720 (fingolimod) for the treatment of patients with relapsing multiple sclerosis, the most common form
View full resource at medicalnewstoday.com
Tags: Multiple Sclerosis, Drug, FDA, Novartis
Most Recently Shared on August 7, 2010 at 3:05 pm By:
FDA Advisory Committee Unanimously Recommends Approval Of Novartis Investigational Treatment FTY720 To Treat Relapsing... http://mnt.to/3H7B
Also Shared By:
FDA advisory committee unanimously recommends approval of Novartis investigational treatment FTY720 to treat relapsing remitting MS
novartis.com — “FDA advisory committee unanimously recommends approval of Novartis investigational treatment FTY720 to treat relapsing remitting MS” View full resource at novartis.com
Most Recently Shared on June 10, 2010 at 11:24 pm By:
Today an FDA advisory committee voted in favor of our investigational therapy for #MS. http://bit.ly/d1K6KF
Advertisement
MNT Pharma News
@mnt_pharma
FDA Advisory Committee Unanimously Recommends Approval Of Novartis Investigational Treatment FTY720 To Treat Relapsing... http://mnt.to/3H7B
1 year ago...